Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-03
1996-11-26
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546167, 546170, 514311, C07D 4002, C07D21552, A61K 3147
Patent
active
055786090
ABSTRACT:
This invention relates to 2-carbocyclic and 2-heterocyclic quinoline-4-carbocyclic acid compounds, and salts thereof, to pharmaceutical compositions comprising such compounds, and to methods of using such compounds for the treatment and/or prevention of organ transplantation rejection, graft versus host disease, and chronic inflammatory diseases, including but not limited to psoriasis and rheumatoid arthritis, in a mammal.
REFERENCES:
patent: 3799929 (1974-03-01), Holmes
patent: 4680299 (1987-07-01), Hesson
patent: 4847381 (1989-07-01), Sutherland et al.
patent: 4861783 (1989-08-01), Ackerman et al.
patent: 4968701 (1990-11-01), Ackerman et al.
patent: 4968702 (1990-11-01), Poletto et al.
patent: 5204329 (1993-04-01), Ackerman et al.
N. P. Buu-Hoi and Lavit, J. Chem. Soc. 2412, 1956.
N. P. Buu-Hoi and Cagniant, Chem. Ber., 76, 1269, 1943.
Batt Douglas G.
Petraitis Joseph J.
Sherk Susan R.
Kondrad Karen H.
Springer David B.
The DuPont Merck Pharmaceutical Company
LandOfFree
2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973425